UBS Group Forecasts Strong Price Appreciation for Allstate (NYSE:ALL) Stock

Allstate (NYSE:ALL - Get Free Report) had its price target upped by investment analysts at UBS Group from $230.00 to $235.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has a "buy" rating on the insurance provider's stock. UBS Group's target price indicates a potential upside of 21.03% from the stock's current price.

ALL has been the topic of several other reports. Keefe, Bruyette & Woods raised their price objective on shares of Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a research report on Wednesday, May 7th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Allstate in a report on Friday, May 16th. Raymond James Financial reissued a "strong-buy" rating and set a $250.00 price target (up from $240.00) on shares of Allstate in a report on Monday, May 5th. Evercore ISI boosted their price objective on Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Finally, Wells Fargo & Company cut their target price on Allstate from $200.00 to $197.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $227.07.

Allstate Stock Performance

NYSE:ALL traded up $0.76 during mid-day trading on Wednesday, hitting $194.16. 1,018,303 shares of the company traded hands, compared to its average volume of 1,639,879. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.40. The stock's fifty day moving average price is $201.24 and its 200-day moving average price is $196.68. The firm has a market cap of $51.42 billion, a price-to-earnings ratio of 11.57, a price-to-earnings-growth ratio of 1.00 and a beta of 0.33. Allstate has a one year low of $158.04 and a one year high of $213.18.

Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a return on equity of 24.62% and a net margin of 6.19%. The firm had revenue of $14.30 billion during the quarter, compared to analysts' expectations of $16.41 billion. During the same period in the prior year, the company posted $5.13 earnings per share. The company's revenue was up 7.8% compared to the same quarter last year. Research analysts anticipate that Allstate will post 18.74 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Allstate

Large investors have recently added to or reduced their stakes in the stock. Arlington Trust Co LLC raised its holdings in shares of Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider's stock worth $25,000 after buying an additional 89 shares during the period. VSM Wealth Advisory LLC bought a new position in Allstate in the 4th quarter valued at $25,000. Hughes Financial Services LLC purchased a new stake in Allstate in the first quarter worth $28,000. Twin Tree Management LP bought a new stake in shares of Allstate during the fourth quarter worth $27,000. Finally, Hopwood Financial Services Inc. bought a new stake in shares of Allstate during the fourth quarter worth $29,000. 76.47% of the stock is owned by institutional investors.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.